FENOFIBRATE FOR REDUCING HYPOGLYCEMIA IN TYPE 1 DIABETES/LADA
作者： Holm Laurits Juulskov , Buschard Karsten , Haupt-Jørgensen Martin
DOI:
关键词: Type 1 diabetes 、 Internal medicine 、 Hypoglycemia 、 Gastroenterology 、 Fenofibrate 、 Medicine
摘要: The present invention relates to compositions comprising Fenofibrate for use in the treatment, prophylaxis and/or prevention of hypoglycaemia type 1 diabetes or other related diseases humans. This is particularly relevant subjects that are genetically predisposed these diseases. daily dose ranges from 1-100 mg/kg bodyweight per day.
lens.org 参考文章(8)
Rodrigo Lucarini, Maria Jose Silvino, Carlos Henrique Gomes Martins, Ademar Alves Silva Filho, Andréa Carla Celotto, Marco Luis Andrade e Silva, Wison Roberto Cunha, Process for obtaining an extract rich in rosmarinic acid (ra) from the plant origanum vulgare and its use for the treatment of diabetes ,(2009)
Istvan Kaldor, Timothy Mark Willson, Robert Anthony Mook, Jeffrey Edmond Cobb, Grady Evan Boswell, Jon Loren Collins, Matthew Jude Sharp, David Norman Deaton, Brad Richard Henke, Marcus Brackeen, John Mark O'callaghan, Greg Alan Erickson, Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma ,(1997)
Itoro E. Elijah, Elisabet Børsheim, Dirk M. Maybauer, Celeste C. Finnerty, David N. Herndon, Marc O. Maybauer, Role of the PPAR-α agonist fenofibrate in severe pediatric burn Burns. ,vol. 38, pp. 481- 486 ,(2012) , 10.1016/J.BURNS.2011.12.004
Reid W. von Borstel, Shalini Sharma, Compounds for the treatment of metabolic disorders ,(2007)
Henry Y. Pan, Michael Bergman, Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor ,(1991)
Mei Li Ng, Carol Wadham, Olga A. Sukocheva, The role of sphingolipid signalling in diabetes‑associated pathologies (Review). International Journal of Molecular Medicine. ,vol. 39, pp. 243- 252 ,(2017) , 10.3892/IJMM.2017.2855
Laurits J. Holm, Lars Krogvold, Jane P. Hasselby, Simranjeet Kaur, Laura A. Claessens, Mark A. Russell, Clayton E. Mathews, Kristian F. Hanssen, Noel G. Morgan, Bobby P. C. Koeleman, Bart O. Roep, Ivan C. Gerling, Flemming Pociot, Knut Dahl-Jørgensen, Karsten Buschard, Abnormal islet sphingolipid metabolism in type 1 diabetes. Diabetologia. ,vol. 61, pp. 1650- 1661 ,(2018) , 10.1007/S00125-018-4614-2
Laurits J. Holm, Martin Haupt-Jorgensen, Jano D. Giacobini, Jane P. Hasselby, Mesut Bilgin, Karsten Buschard, Fenofibrate increases very-long-chain sphingolipids and improves blood glucose homeostasis in NOD mice. Diabetologia. ,vol. 62, pp. 2262- 2272 ,(2019) , 10.1007/S00125-019-04973-Z